Zhang Q - Search Results

1

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial.

Blayney DW, Mohanlal R, Adamchuk H, Kirtbaya DV, Chen M, Du L, Ogenstad S, Ginn G, Huang L, Zhang Q. Blayney DW, et al. Among authors: zhang q. JAMA Netw Open. 2022 Jan 4;5(1):e2145446. doi: 10.1001/jamanetworkopen.2021.45446. JAMA Netw Open. 2022. PMID: 35084480 Free PMC article. Clinical Trial.

2

Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma.

Ji H, Niu X, Yin L, Wang Y, Huang L, Xuan Q, Li L, Zhang H, Li J, Yang Y, An W, Zhang Q. Ji H, et al. Among authors: zhang q, zhang h. Cell Physiol Biochem. 2018;45(3):951-961. doi: 10.1159/000487288. Epub 2018 Feb 2. Cell Physiol Biochem. 2018. PMID: 29428948 Free article.

3

The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update.

Huang L, Liang G, Zhang Q, Zhao W. Huang L, et al. Among authors: zhang q. J Breast Cancer. 2020 Apr;23(2):129-140. doi: 10.4048/jbc.2020.23.e10. J Breast Cancer. 2020. PMID: 32395373 Free PMC article. Review.

4

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

Blayney DW, Zhang Q, Feng J, Zhao Y, Bondarenko I, Vynnychenko I, Kovalenko N, Nair S, Ibrahim E, Udovista DP, Mohanlal R, Ogenstad S, Ette E, Du L, Huang L, Shi YK. Blayney DW, et al. Among authors: zhang q. JAMA Oncol. 2020 Nov 1;6(11):e204429. doi: 10.1001/jamaoncol.2020.4429. Epub 2020 Nov 12. JAMA Oncol. 2020. PMID: 32970104 Free PMC article. Clinical Trial.

5

Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.

Xu B, Zhang Q, Sun T, Li W, Teng Y, Hu X, Bondarenko I, Adamchuk H, Zhang L, Trukhin D, Wang S, Zheng H, Tong Z, Shparyk Y, Wang Q; HLX02-BC01 Investigators. Xu B, et al. Among authors: zhang l, zhang q. BioDrugs. 2021 May;35(3):337-350. doi: 10.1007/s40259-021-00475-w. Epub 2021 Apr 7. BioDrugs. 2021. PMID: 33826080 Free PMC article. Clinical Trial.

6

[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].

Xu B, Tian F, Yu J, Song Y, Shi J, Zhang B, Zhang Y, Yuan Z, Wu Q, Zhang Q, Nan K, Sun Q, Li W, Hu J, Bi J, Meng C, Dai H, Jiang H, Yue S, Cao B, Sun Y, Wang S, Tong Z, Shen P, Wu G, Tang L, Deng Y, Jia L, Shen K, Zhuang W, Xie X, Wu Y, Chen L. Xu B, et al. Among authors: zhang b, zhang q, zhang y. Zhonghua Zhong Liu Za Zhi. 2016 Jan;38(1):23-7. doi: 10.3760/cma.j.issn.0253-3766.2016.01.005. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 26796802 Clinical Trial. Chinese.

7

The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis.

Zhao S, Zhang M, Zhang Y, Meng H, Wang Y, Liu Y, Jing J, Huang L, Sun M, Zhang Y, Zhang Q. Zhao S, et al. Among authors: zhang m, zhang q, zhang y. Cancer Biol Med. 2018 Aug;15(3):290-298. doi: 10.20892/j.issn.2095-3941.2018.0047. Cancer Biol Med. 2018. PMID: 30197796 Free PMC article.

8

Systemic immune response associated with radiation therapy in B‑cell non‑Hodgkin's lymphoma of Waldeyer's ring.

Niu X, Ji H, Wang Y, Hu S, Xuan Q, Huang L, Yin L, Su W, Li L, Zhang H, Li J, Yang Y, An W, Zhang Q. Niu X, et al. Among authors: zhang q, zhang h. Oncol Rep. 2018 Dec;40(6):3674-3684. doi: 10.3892/or.2018.6748. Epub 2018 Sep 28. Oncol Rep. 2018. PMID: 30272309

9

High Expression of Plakoglobin Promotes Metastasis in Invasive Micropapillary Carcinoma of the Breast via Tumor Cluster Formation.

Huang L, Ji H, Yin L, Niu X, Wang Y, Liu Y, Xuan Q, Li L, Zhang H, Zhou X, Li J, Cui C, Yang Y, An W, Zhang Q. Huang L, et al. Among authors: zhang q, zhang h. J Cancer. 2019 Jun 2;10(12):2800-2810. doi: 10.7150/jca.31411. eCollection 2019. J Cancer. 2019. PMID: 31258788 Free PMC article.

10

Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical Trial.

Fan Y, Sun T, Shao Z, Zhang Q, Ouyang Q, Tong Z, Wang S, Luo Y, Teng Y, Wang X, Wang S, Liu Q, Feng J, Shen K, Song Y, Wang J, Ma F, Li Q, Zhang P, Xu B. Fan Y, et al. Among authors: zhang p, zhang q. JAMA Oncol. 2021 Oct 1;7(10):e213428. doi: 10.1001/jamaoncol.2021.3428. Epub 2021 Oct 21. JAMA Oncol. 2021. PMID: 34436536 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70,322 results

Search Page

Filters